A Los Angeles-based apartment developer has acquired a Thousand Oaks property formerly owned by the biotech giant Amgen. The 8.2-acre site, at 150 Hillcrest Drive, is entitled for 333 residential units, including 20% affordable units, according to The Latigo Group. TLG is the real estate investment and development company that acquired the property. Brooke HollandCommercial…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
